v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Company's Stock Option Activity
The following table summarizes the Company’s stock option activity (in thousands, except share and per share amounts):
Number of
Options		Weighted Avg
Exercise Price		Weighted Avg
Remaining
Contractual Life
(Years)		Aggregate
Intrinsic Value
(in thousands)
Outstanding as of December 31, 202531,294,637$0.66 6.29$203,535 
Granted5,577,01713.21 
Exercised(9,322,163)0.51 
Forfeited/Cancelled(507,472)9.42 
Outstanding as of June 30, 202627,042,019$3.14 7.34$275,706 
As of June 30, 2026
Exercisable17,975,356$0.92 6.55$222,895 
Summary of the Restricted Stock Awards
The table below presents the activity of the RSAs:
RSAs
Outstanding		Weighted Average
Grant Date Fair
Value
Unvested as of December 31, 2025419,590$0.89 
Granted—— 
Vested(179,825)0.89 
Forfeited—— 
Unvested as of June 30, 2026239,766$0.89 
The table below presents the activity of the RSUs:

RSUs
Outstanding		Weighted Average
Grant Date Fair
Value
Unvested as of December 31, 2025—$— 
Granted743,74012.49 
Vested(15,462)12.41 
Forfeited—— 
Unvested as of June 30, 2026728,278$12.49 
Summary of Total Stock-based Compensation Expense
Total stock-based compensation expense is included within the condensed consolidated statement of operations and comprehensive loss as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Cost of revenue$1,821 $109 $2,838 $201 
Research and development4,820 116 7,234 188 
Selling, general and administrative5,425 544 10,287 1,498 
Total stock-based compensation expense$12,066 $769 $20,359 $1,887